{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041546","form_type":"8-K","ticker":"CURX","cik":"0002025942","company_name":"Curanex Pharmaceuticals Inc","filed_at":"2026-09-04T20:15:30+00:00","discovered_at":"2026-09-04T20:16:00.476805+00:00","generated_at":"2026-09-04T20:16:05.638837+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Curanex regains Nasdaq minimum bid price compliance after 1-for-20 reverse split","bullets":["On Sept 3, 2026, Nasdaq confirmed closing bid price >= $1.00 for 10 straight business days (Aug 20-Sep 2).","Company effected 1-for-20 reverse stock split on Aug 20, 2026 to cure bid price deficiency.","Originally notified Nov 5, 2025 of non-compliance with Nasdaq Listing Rule 5550(a)(2).","Nasdaq has closed the matter; CURX remains listed on The Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041546","json":"https://secwatch.observer/filing/0001493152-26-041546.json","markdown":"https://secwatch.observer/filing/0001493152-26-041546.md","text":"https://secwatch.observer/filing/0001493152-26-041546.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2025942/000149315226041546/0001493152-26-041546-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2025942/000149315226041546/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-04T20:16:05.638837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}